Linden Thomas Advisory Services »

Vertex Pharmaceuticals Incorporated shares owned by Linden Thomas Advisory Services

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Linden Thomas Advisory Services from 13F filings

Historical chart of Linden Thomas Advisory Services investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Linden Thomas Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Linden Thomas Advisory Services

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.6M 6.3k 418.01
2023-12-31 $2.4M 6.0k 406.89
2023-09-30 $1.9M 5.5k 347.74
2023-06-30 $4.4M 13k 351.91
2023-03-31 $3.8M 12k 315.07
2022-12-31 $3.3M 12k 288.78

More positions owned by Linden Thomas Advisory Services

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Broadcom (AVGO)
salesforce (CRM)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Chemed Corp Com Stk (CHE)
Netflix (NFLX)
Lam Research Corporation (LRCX)
Intuit (INTU)
Gartner (IT)
Adobe Systems Incorporated (ADBE)
Lockheed Martin Corporation (LMT)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Linden Thomas Advisory Services

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
BlackRock
FMR
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
T. Rowe Price Associates
Amundi
Morgan Stanley
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated